Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact.

McCaffery K, Waller J, Forrest S, Cadman L, Szarewski A, Wardle J.

BJOG. 2004 Dec;111(12):1437-43. Erratum in: BJOG. 2004 Dec;111(12):1489.

2.

The psychosocial impact of human papillomavirus testing in primary cervical screening-a study within a randomized trial.

Kitchener HC, Fletcher I, Roberts C, Wheeler P, Almonte M, Maguire P.

Int J Gynecol Cancer. 2008 Jul-Aug;18(4):743-8. Epub 2007 Oct 18.

PMID:
17944916
3.

The psychosocial burden of human papillomavirus related disease and screening interventions.

Pirotta M, Ung L, Stein A, Conway EL, Mast TC, Fairley CK, Garland S.

Sex Transm Infect. 2009 Dec;85(7):508-13. doi: 10.1136/sti.2009.037028. Epub 2009 Aug 24.

PMID:
19703844
5.

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.

Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Forslund O, Hansson BG, Hagmar B, Johansson B, Rylander E, Dillner J.

J Natl Cancer Inst. 2009 Jan 21;101(2):88-99. doi: 10.1093/jnci/djn444. Epub 2009 Jan 13.

6.

Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.

Papa D, Moore Simas TA, Reynolds M, Melnitsky H.

J Low Genit Tract Dis. 2009 Apr;13(2):66-71. doi: 10.1097/LGT.0b013e31818a53f0.

PMID:
19387125
7.

Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study.

Kwan TT, Cheung AN, Lo SS, Lee PW, Tam KF, Chan KK, Ngan HY.

Acta Obstet Gynecol Scand. 2011 May;90(5):445-51. doi: 10.1111/j.1600-0412.2011.01092.x. Epub 2011 Mar 16.

PMID:
21306349
8.

Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial.

McCaffery KJ, Irwig L, Turner R, Chan SF, Macaskill P, Lewicka M, Clarke J, Weisberg E, Barratt A.

BMJ. 2010 Feb 23;340:b4491. doi: 10.1136/bmj.b4491.

9.

Human papillomavirus infections and risks of cervical cancer: what do women know?

Pitts M, Clarke T.

Health Educ Res. 2002 Dec;17(6):706-14.

10.

'I don't care whether it's HPV or ABC, I just want to know if I have cancer.' Factors influencing women's emotional responses to undergoing human papillomavirus testing in routine management in cervical screening: a qualitative study.

O'Connor M, Costello L, Murphy J, Prendiville W, Martin CM, O'Leary JJ, Sharp L; Irish Screening Research Consortium (CERVIVA).

BJOG. 2014 Oct;121(11):1421-9. doi: 10.1111/1471-0528.12741. Epub 2014 Apr 1.

11.
12.

Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.

Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.

BJOG. 2006 Nov;113(11):1303-7. Epub 2006 Sep 15.

13.

Information and cervical screening: a qualitative study of women's awareness, understanding and information needs about HPV.

Goldsmith MR, Bankhead CR, Kehoe ST, Marsh G, Austoker J.

J Med Screen. 2007;14(1):29-33.

PMID:
17362569
14.

[Evaluation of gene chip technology for high risk type human papillomavirus in cervical cancer screening].

Li RZ, Shi JF, Zhou QZ, Wu RF, Li N, Wu LN, Zhou YQ, Wang Q, Liu ZH, Liu B, Qiao YL.

Zhonghua Yi Xue Za Zhi. 2006 Feb 7;86(5):307-11. Chinese.

PMID:
16677522
15.

Human papillomavirus testing for primary screening in women at low risk of developing cervical cancer. The Greek experience.

Agorastos T, Dinas K, Lloveras B, de Sanjose S, Kornegay JR, Bonti H, Bosch FX, Constantinidis T, Bontis J.

Gynecol Oncol. 2005 Mar;96(3):714-20.

PMID:
15721416
16.
17.

Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less.

Pretorius RG, Peterson P, Azizi F, Burchette RJ.

Am J Obstet Gynecol. 2006 Nov;195(5):1260-5.

PMID:
17074547
18.
19.

Human papillomavirus testing for cervical cancer screening: results from a 6-year prospective study in rural China.

Shi JF, Belinson JL, Zhao FH, Pretorius RG, Li J, Ma JF, Chen F, Xiang W, Pan QJ, Zhang X, Zhang WH, Qiao YL, Smith JS.

Am J Epidemiol. 2009 Sep 15;170(6):708-16. doi: 10.1093/aje/kwp188. Epub 2009 Aug 19.

20.

Women's experiences of repeated HPV testing in the context of cervical cancer screening: a qualitative study.

Waller J, McCaffery K, Kitchener H, Nazroo J, Wardle J.

Psychooncology. 2007 Mar;16(3):196-204.

Items per page

Supplemental Content

Write to the Help Desk